PathoCare

Houston, United States

Developer of rapid, non-invasive, and cost-effective diagnostic tests for respiratory infections.

$150.2M raised

Dec 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PathoCare raised?

PathoCare has raised $150.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.

Who are PathoCare's investors?

PathoCare's investors include Hamershlag Private.

Where is PathoCare headquartered?

PathoCare is headquartered in Houston, United States.

What does PathoCare do?

Developer of rapid, non-invasive, and cost-effective diagnostic tests for respiratory infections.

What stage is PathoCare at?

PathoCare is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 31, 2024.

MLA

"PathoCare — Funding & Investors." VCBacked, December 31, 2024, https://www.vcbacked.co/company/pathocare. Accessed July 3, 2026.

APA

VCBacked. (2024). PathoCare — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/pathocare

Wikipedia (cite web)

{{cite web |title=PathoCare — Funding & Investors |url=https://www.vcbacked.co/company/pathocare |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 31, 2024.